J Virol 1998;Dehydroemetine web seventy two(4):3235?0. Creation and characterization of simian-human immunodeficiency virus- like particles. AIDS ResHumRetroviruses 2000;16(three):227?six. 21. Guo L, Lu X, Kang SM, Chen C, Compans RW, Yao Q. Improvement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles. Virology 2003;313(2):502?3. [PubMed: 12954217] 22. Takahashi H, Cohen J, Hosmalin A, Stop KB, Houghten R, Cornette JL, et al. An immunodominant epitope with the human immunodeficiency virus envelope glycoprotein gp160 identified by class I key histocompatibility elaborate molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 1988;85(nine):3105?. [PubMed: 2452443] 23. Quan FS, Matsumoto T, Lee JB, Timothy O, Kim TS, Joo KH, et al. Immunization with Trichinella spiralis Korean isolate larval excretory-secretory antigen induces defense and lymphocyte subset adjustments in rats. Immunol Devote 2004;33(1):15?6. [PubMed: 15015829] 24. Chackerian B, Haigwood NL, Overbaugh J. Characterization of a CD4-expressing macaque mobile PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/25843411?dopt=Abstract line which will Pyronaridine tetraphosphate In Vivo detect virus just after an individual replication cycle and will be contaminated by Mdivi-1 Autophagy diverse simian immunodeficiency virus isolates. Virology 1995;213(2):386?4. [PubMed: 7491763] 25. Sailaja G, Husain S, Nayak BP, Jabbar AM. Long-term servicing of gp120-specific immune responses by genetic vaccination along with the HIV-1 envelope genes joined for the gene encoding Flt-3 ligand. J Immunol 2003;170(5):2496?07.Ion of opportunity glycosylation websites of your sort 1 recombinant human immunodeficiency
Ion of possible glycosylation web sites in the variety one recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990;265(18):10373?2. [PubMed: 2355006] 16. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Framework of the HIV gp120 envelope glycoprotein in elaborate with all the CD4 receptor as well as a neutralizing human antibody. Nature 1998;393(6686):648?9. [PubMed: 9641677] seventeen. Kang SM, Quan FS, Huang C, Guo L, Ye L, Yang C, et al. Modified HIV envelope proteins with increased binding to neutralizing monoclonal antibodies. Virology 2005;331(one):20?2. [PubMed: 15582650] 18. Jones DH, McBride BW, Roff MA, Maloney V, Farrar GH. Purification and characterization of simian immunodeficiency virus (SIVmac) envelope glycoprotein gp130 from virus-infected cells. Vaccine 1994;12(3):250?eight. [PubMed: 8165858] 19. Kang SM, Guo L, Yao Q, Skountzou I, Compans RW. Intranasal immunization with inactivated influenza virus boosts immune responses to coadministered simian-human immunodeficiency virus-like particle antigens. J Virol 2004;78(18):9624?two. [PubMed: 15331695] twenty. Yao Q, Kuhlmann FM, Eller R, Compans RW, Chen C. Manufacturing and characterization of simian-human immunodeficiency virus- like particles. AIDS ResHumRetroviruses 2000;16(3):227?six. 21. Guo L, Lu X, Kang SM, Chen C, Compans RW, Yao Q. Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles. Virology 2003;313(two):502?three. [PubMed: 12954217] 22. Takahashi PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/25772545?dopt=Abstract H, Cohen J, Hosmalin A, Stop KB, Houghten R, Cornette JL, et al.